Literature DB >> 1714807

Slowing of EEG in Parkinson's disease.

R Soikkeli1, J Partanen, H Soininen, A Pääkkönen, P Riekkinen.   

Abstract

EEG studies of Parkinson's disease (PD) have shown that the incidence of EEG abnormalities is higher than in normal old individuals. The most common alteration in PD is generalized slowing of the EEG. We studied 18 patients with Parkinson dementia, 18 age-matched Parkinson patients without dementia and 20 controls. The absolute and relative amplitudes of delta, theta, alpha and beta bands and the peak and mean frequency were calculated from EEG spectra recorded from the T6-O2 derivation. All variables differed significantly in Parkinson dementia patients compared to controls. The most conspicuous finding was the increase of delta activity. Parkinsonian patients without dementia had more theta activity and the frequencies were slow compared to controls. We conclude that parkinsonian subgroups have distinct patterns of abnormality in EEG spectra: Parkinson patients with dementia have distinctly slower EEGs than patients without dementia.

Entities:  

Mesh:

Year:  1991        PMID: 1714807     DOI: 10.1016/0013-4694(91)90134-p

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  55 in total

1.  Quantitative EEG as a predictive biomarker for Parkinson disease dementia.

Authors:  B T Klassen; J G Hentz; H A Shill; E Driver-Dunckley; V G H Evidente; M N Sabbagh; C H Adler; J N Caviness
Journal:  Neurology       Date:  2011-06-01       Impact factor: 9.910

Review 2.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

3.  Open Ephys electroencephalography (Open Ephys  +  EEG): a modular, low-cost, open-source solution to human neural recording.

Authors:  Christopher Black; Jakob Voigts; Uday Agrawal; Max Ladow; Juan Santoyo; Christopher Moore; Stephanie Jones
Journal:  J Neural Eng       Date:  2017-03-07       Impact factor: 5.379

4.  Non-linear dynamical analysis of multichannel EEG: clinical applications in dementia and Parkinson's disease.

Authors:  K J Stam; D L Tavy; B Jelles; H A Achtereekte; J P Slaets; R W Keunen
Journal:  Brain Topogr       Date:  1994       Impact factor: 3.020

5.  Electrophysiological and structural aspects in the frontal cortex after the bee (Apis mellifera) venom experimental treatment.

Authors:  Adrian Florea; Constantin Puică; Mihaela Vinţan; Ileana Benga; Constantin Crăciun
Journal:  Cell Mol Neurobiol       Date:  2011-02-26       Impact factor: 5.046

6.  Relationship between oscillatory activity in the cortico-basal ganglia network and parkinsonism in MPTP-treated monkeys.

Authors:  Annaelle Devergnas; Damien Pittard; Donald Bliwise; Thomas Wichmann
Journal:  Neurobiol Dis       Date:  2014-04-21       Impact factor: 5.996

7.  Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography.

Authors:  R R Llinás; U Ribary; D Jeanmonod; E Kronberg; P P Mitra
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

8.  Reduced Rapid Eye Movement Density in Parkinson Disease: A Polysomnography-Based Case-Control Study.

Authors:  Lynn A Schroeder; Olivier Rufra; Nicolas Sauvageot; François Fays; Vannina Pieri; Nico J Diederich
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

9.  Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance.

Authors:  Ramalingam Vetrivelan; Mei-Hong Qiu; Celene Chang; Jun Lu
Journal:  Front Neuroanat       Date:  2010-11-23       Impact factor: 3.856

10.  Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease.

Authors:  David H Benninger; Mikhail Lomarev; Eric M Wassermann; Grisel Lopez; Elise Houdayer; Rebecca E Fasano; Nguyet Dang; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2009-03-14       Impact factor: 3.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.